JPRN-UMIN000004750招募中未知
The study of efficacy of AT1 receptor blocker, olmesartan and calcium antagonists , azelnidipine combination therapy in patients with essential hypertension , diabetic or chronic kidney disease - The study of efficacy of AT1 receptor blocker, olmesartan and calcium antagonists , azelnidipine combination therapy in patients with essential hypertension , diabetic or chronic kidney disease (HARIMAYA study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •SCr > 3.0mg/dl Patient has liver dysfunction. It is a developing patient within six months as for cardiac infarction or the apoplexy. Patient who has possibility of pregnancy or pregnancy. Patient while suckling. Patient who judged that doctor is improper
研究者
相似试验
招募中
不适用
The effects of AT1 receptor blocker (telmisartan) on serum lipid with hypertensive patients associated with multiple risk factors for cardiovascular diseaseDiabetes MellitusJPRN-UMIN000007705Chiba University Hospital30
招募中
不适用
The effect of AT1 receptor blocker/Ca antagonist combination drug on hypertensive patients - Effect of change in medication from AT1 receptor blocker/Ca antagonist concurrent dosage to its combination drugHypertensionJPRN-UMIN000007701Chiba University Hospital100
进行中（未招募）
不适用
Study to investigate the effect of the A1 agonist capadenoson on ventricular HR in patients with persistent or permanent atrial fibrillation by administration of capadenoson in a dose of 4 mg once daily for five daysMedDRA version: 9.1Level: LLTClassification code 10016566Term: Fibrillation atrialAtrial fibrillationEUCTR2007-003619-30-DEBayer HealthCare AG
尚未招募
2 期
Study of the effect of telmisartan on fibrosis in fatty liver diseaseon-alcoholic steatohepatitis (NASH)Non-alcoholic steatohepatitis (NASH)Inflammatory and Immune System - LiverACTRN12606000411549Professor Peter Angus40
进行中（未招募）
不适用
Effect of selective alpha 1A receptor antagonists on the iris dilator muscleEffect of selective alpha 1A receptor antagonists on the iris dilator muscleEUCTR2015-003061-28-ATVienna Institute for Research in Ocular Surgery